This article has been corrected from a previous version that ran yesterday. GE Healthcare is providing the Cy3 and Cy5 dyes under the agreement, not the Universal Linkage System, which was developed by Kreatech.
NEW YORK, Feb. 22 (GenomeWeb News) - Kreatech Biotechnology said yesterday that it has signed an agreement allowing it to use GE Healthcare's Cy3 and Cy5 dyes in combination with its Universal Linkage System in DNA microarray-labeling kits.
Under the terms of the agreement, Kreatech gains global rights for the use of Cy3 and Cy5 dyes with the Universal Linkage System in fluorescent applications within the life sciences market, Kreatech said. Kreatech will use the technology to develop and manufacture microarray-labeling kits for amplified RNA labeling and genomic DNA labeling, it said.
Kreatech said the technology enables direct DNA labeling, negating the need for modified nucleotides.
Financial terms of the deal were not disclosed.